Noah Jones on November 20, 2026 7:24 pm Silver leverage is strong here; beta cuts both ways though. Reply
Ava Thomas on November 20, 2026 7:24 pm The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Liam Moore on November 20, 2026 7:25 pm Interesting update on “My Brother’s Death Led Me Here” -Ed Calderon. Curious how the grades will trend next quarter. Reply
Olivia Rodriguez on November 20, 2026 7:26 pm Silver leverage is strong here; beta cuts both ways though. Reply
Noah Lopez on November 20, 2026 7:26 pm Nice to see insider buying—usually a good signal in this space. Reply
Patricia Martin on November 20, 2026 7:29 pm I like the balance sheet here—less leverage than peers. Reply
Oliver Hernandez on November 20, 2026 7:30 pm Interesting update on “My Brother’s Death Led Me Here” -Ed Calderon. Curious how the grades will trend next quarter. Reply
Elizabeth Smith on November 20, 2026 7:30 pm Uranium names keep pushing higher—supply still tight into 2026. Reply
William Miller on November 20, 2026 7:30 pm Uranium names keep pushing higher—supply still tight into 2026. Reply
Noah H. Hernandez on November 20, 2026 7:31 pm Uranium names keep pushing higher—supply still tight into 2026. Reply
Ava Rodriguez on November 20, 2026 7:31 pm Uranium names keep pushing higher—supply still tight into 2026. Reply
Emma Brown on November 20, 2026 7:32 pm The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Robert Smith on November 20, 2026 7:34 pm Silver leverage is strong here; beta cuts both ways though. Reply
Emma Thompson on November 20, 2026 7:34 pm The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Ava Thompson on November 20, 2026 7:35 pm The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Amelia S. Hernandez on November 20, 2026 7:46 pm Good point. Watching costs and grades closely. Reply
James Davis on November 20, 2026 7:36 pm Silver leverage is strong here; beta cuts both ways though. Reply
40 Comments
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Interesting update on “My Brother’s Death Led Me Here” -Ed Calderon. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Interesting update on “My Brother’s Death Led Me Here” -Ed Calderon. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Uranium names keep pushing higher—supply still tight into 2026.
Good point. Watching costs and grades closely.
Uranium names keep pushing higher—supply still tight into 2026.
Good point. Watching costs and grades closely.
Uranium names keep pushing higher—supply still tight into 2026.
Good point. Watching costs and grades closely.
Uranium names keep pushing higher—supply still tight into 2026.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.